Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors, as well as accessories, such as test strips and lancing devices medical equipment companies, pharmacies, and hospitals. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments. The company was incorporated in 2003 and is based in Taichung, Taiwan.
Bionime Dividend Announcement
• Bionime announced a annually dividend of NT$2.00 per ordinary share which will be made payable on 2024-08-23. Ex dividend date: 2024-07-29
• Bionime annual dividend for 2024 was NT$2.00
• Bionime annual dividend for 2023 was NT$2.10
• Bionime's trailing twelve-month (TTM) dividend yield is 2.99%
• Bionime's dividend growth over the last five years (2018-2023) was -12.70% year
• Bionime's dividend growth over the last ten years (2013-2023) was 10.32% year
Bionime Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-29 | NT$2.00 | annually | 2024-08-23 |
2023-07-24 | NT$2.10 | annually | 2023-08-18 |
2022-07-21 | NT$2.00 | annually | 2022-08-19 |
2021-07-26 | NT$2.06 | annually | 2021-08-20 |
2020-07-23 | NT$1.99 | annually | 2020-08-21 |
2019-08-01 | NT$2.00 | annually | 2019-08-30 |
2018-07-09 | NT$4.14 | annually | 2018-08-15 |
2017-07-10 | NT$2.77 | annually | 2017-08-04 |
2016-07-28 | NT$0.60 | annually | |
2015-08-31 | NT$0.94 | annually | |
2014-09-04 | NT$1.75 | annually | |
2013-08-22 | NT$0.79 | annually |
Bionime Dividend per year
Bionime Dividend growth
Bionime Dividend Yield
Bionime current trailing twelve-month (TTM) dividend yield is 2.99%. Interested in purchasing Bionime stock? Use our calculator to estimate your expected dividend yield:
Bionime Financial Ratios
Bionime Dividend FAQ
Other factors to consider when evaluating Bionime as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Bionime stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Bionime's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Bionime publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Bionime distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Bionime are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Bionime sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Bionime distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Bionime declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Bionime's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Bionime's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.